Milk intake and survival in newborn cannabinoid CB1 receptor knockout mice: Evidence for a "CB3" receptor

European Journal of Pharmacology

Volumn 461, Issue 1, 2003, Pages 27-34

  Fride, Ester ^a   Foox, Anat ^a   Rosenberg, Elana ^c   Faigenboim, Moran ^a   Cohen, Vickey ^a   Barda, Lena ^a   Blau, Hannah ^b   Mechoulam, Raphael ^c  

^a ARIEL UNIVERSITY   (Israel)

^b SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^c NONE

Author keywords

2 Arachidonoyl glycerol; Cannabidiol; Cannabinoid receptor; Endocannabinoid; Milk suckling; SR141716A

Indexed keywords

2 ARACHIDONOYLGLYCEROL; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; CANNABINOID 1 RECEPTOR; CANNABINOID DERIVATIVE; CANNABINOID RECEPTOR AGONIST; CP 5591405; CP 559405; RIMONABANT; UNCLASSIFIED DRUG;

AGE; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE CALCULATION; DRUG EFFECT; FOOD INTAKE; KNOCKOUT MOUSE; MOUSE; MOUSE STRAIN; NEWBORN; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; RECEPTOR BLOCKING; SURVIVAL; SURVIVAL RATE; TIME; WEIGHT GAIN;

EID: 0037423029     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(03)01295-0     Document Type: Article

References (38)

1. Abel E.L. Effects of marihuana on the solution of anagrams, memory and appetite. Nature. 231:1971;260-261.
2. Belue R.C., Howlett A.C., Westlake T.M., Hutchings D.E. The ontogeny of cannabinoid receptors in the brain of postnatal and aging rats. Neurotoxicol. Teratol. 17:1995;25-30.
3. Berrendero F., Sepe N., Ramos J.A., Di Marzo V., Fernandez-Ruiz J.J. Analysis of cannabinoid receptor binding and mRNA expression and endogenous cannabinoid contents in the developing rat brain during late gestation and early postnatal period. Synapse. 33:1999;181-191.
4. Biegon A., Kerman I.A. Autoradiographic study of pre- and postnatal distribution of cannabinoid receptors in human brain. NeuroImage. 14:2001;1463-1468.
5. Breivogel C.S., Griffin G., Di Marzo V., Martin B.R. Evidence for a new G protein-coupled cannabinoid receptor in mouse brain. Mol. Pharmacol. 60:2001;155-163.
6. Buckley N.E., Hansson S., Harta G., Mezey E. Expression of the CB1 and CB2 receptor messenger RNAs during embryonic development in the rat. Neuroscience. 82:1998;1131-1149.
7. Devane W.A., Dysarz F.A. III, Johnson M.R., Melvin L.S., Howlett A.C. Determination and characterization of a cannabinoid receptor in rat brain. Mol. Pharmacol. 34:1988;605-613.
8. Devane W.A., Hanus L., Breuer A., Pertwee R.G., Stevenson L.A., Griffin G., Gibson D., Mandelbaum A., Etinger A., Mechoulam R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science. 258:1992;1946-1949.
9. Di Marzo V. 'Endocannabinoids' and other fatty acid derivatives with cannabimimetic properties: biochemistry and possible physiopathological relevance. Biochim. Biophys. Acta. 1392:1998;153-175.
10. Di Marzo V., Fontana A. Anandamide, an endogenous cannabinomimetic eicosanoid: 'killing two birds with one stone'. Prostaglandins Leukot. Essent. Fat. Acids. 53:1995;1-11.
11. Di Marzo V., Sepe N., De Petrocellis L., Berger A., Crozier G., Fride E., Mechoulam R. Trick or treat from food endocannabinoids? Nature. 396:1998;636-637.
12. Di Marzo V., Breivogel C.S., Tao Q., Bridgen D.T., Razdan R.K., Zimmer A.M., Zimmer A., Martin B.R. Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain. J. Neurochem. 75:2000;2434-2444.
13. Fernandez-Ruiz J., Berrendero F., Hernandez M.L., Ramos J.A. The endogenous cannabinoid system and brain development. Trends Neurosci. 23:2000;14-20.
14. Fride E. Cannabinoids and feeding: the role of the endogenous cannabinoid system as a trigger for newborn suckling. J. Cannabis Ther. 2:2002;51-62.
15. Fride E. Endocannabinoids in the central nervous system - an overview. Prostaglandins Leukot. Essent. Fat. Acids. 66:2002;221-233.
16. Fride E., Mechoulam R. Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent. Eur. J. Pharmacol. 231:1993;313-314.
17. Fride E., Mechoulam R. Ontogenetic development of the response to anandamide and delta 9-tetrahydrocannabinol in mice. Brain Res. Dev. Brain Res. 95:1996;131-134.
18. Fride E., Sanudo-Pena C. Cannabinoids and endocannabinoids: behavioral and developmental aspects. Onaivi E. The Biology of Marijuana. 2002;Harwood Academic Publishers, Reading.
19. Fride E., Weinstock M. The effects of prenatal exposure to predictable or unpredictable stress on early development in the rat. Dev. Psychobiol. 17:1984;651-660.
20. Fride E., Ginzburg Y., Breuer A., Bisogno T., Di Marzo V., Mechoulam R. Critical role of the endogenous cannabinoid system in mouse pup suckling and growth. Eur. J. Pharmacol. 419:2001;207-214.
21. Gaoni Y., Mechoulam R. The isolation and structure of delta-1-tetrahydrocannabinol and other neutral cannabinoids from hashish. J. Am. Chem. Soc. 93:1971;217-224.
22. Hanus L., Abu-Lafi S., Fride E., Breuer A., Vogel Z., Shalev D.E., Kustanovich I., Mechoulam R. 2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor. Proc. Natl. Acad. Sci. U. S. A. 98:2001;3662-3665.
23. Ledent C., Valverde O., Cossu G., Petitet F., Aubert J.F., Beslot F., Bohme G.A., Imperato A., Pedrazzini T., Roques B.P., Vassart G., Fratta W., Parmentier M. Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science. 283:1999;401-404.
24. Maldonado R. Opioid system involvement in cannabinoid tolerance and dependence. Maldonado R. Molecular Biology of Drug Addiction. 2002;Humana Press, Totowa.
25. Matsuda L.A., Lolait S.J., Brownstein M.J., Young A.C., Bonner T.I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature. 346:1990;561-564.
26. McLaughlin C.R., Abood M.E. Developmental expression of cannabinoid receptor mRNA. Brain Res. Dev. Brain Res. 76:1993;75-78.
27. McLaughlin C.R., Martin B.R., Compton D.R., Abood M.E. Cannabinoid receptors in developing rats: detection of mRNA and receptor binding. Drug Alcohol Depend. 36:1994;27-31.
28. Mechoulam R., Ben-Shabat S., Hanus L., Ligumsky M., Kaminski N.E., Schatz A.R., Gopher A., Almog S., Martin B.R., Compton D.R.et al. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem. Pharmacol. 50:1995;83-90.
29. Munro S., Thomas K.L., Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature. 365:1993;61-65.
30. Pertwee R.G. Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol. Ther. 74:1997;129-180.
31. Pertwee R.G., Ross R.A. Cannabinoid receptors and their ligands. Prostaglandins Leukot. Essent. Fat. Acids. 66:2002;101-121.
32. Petrov E.S., Varlinskaya E.I., Smotherman W.P. Endogenous opioids and the first suckling episode in the rat. Dev. Psychobiol. 33:1998;175-183.
33. Porter A.C., Sauer J.M., Knierman M.D., Becker G.W., Berna M.J., Bao J., Nomikos G.G., Carter P., Bymaster F.P., Leese A.-B., Felder C.C. Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor. J. Pharmacol. Exp. Ther. 301:2002;1020-1024.
34. Rinaldi-Carmona M., Barth F., Heaulme M., Shire D., Calandra B., Congy C., Martinez S., Maruani J., Neliat G., Caput D.et al. SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett. 350:1994;240-244.
35. Rinaldi-Carmona M., Barth F., Millan J., Derocq J.M., Casellas P., Congy C., Oustric D., Sarran M., Bouaboula M., Calandra B., Portier M., Shire D., Breliere J.C., Le Fur G.L. SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor. J. Pharmacol. Exp. Ther. 284:1998;644-650.
36. Rodriguez de Fonseca F., Ramos J.A., Bonnin A., Fernandez-Ruiz J.J. Presence of cannabinoid binding sites in the brain from early postnatal ages. NeuroReport. 4:1993;135-138.
37. Williams C.M., Kirkham T.C. Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors. Psychopharmacology. 143:1999;315-317.
38. Zimmer A., Zimmer A.M., Hohmann A.G., Herkenham M., Bonner T.I. Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. Proc. Natl. Acad. Sci. U. S. A. 96:1999;5780-5785.